1. Three Decades of Atherosclerotic Reno-vascular Disease Management - Changing Outcomes in an Observational Study
Kidney Blood Press Res 2016;41: DOI: /
Fig. 1. Proportion of patients in each group receiving specific vascular protective agents (renin angiotensin blockage, beta-blockers, statins or aspirin) at time of diagnosis.
© 2016 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4.0

2. Three Decades of Atherosclerotic Reno-vascular Disease Management - Changing Outcomes in an Observational Study
Kidney Blood Press Res 2016;41: DOI: /
Fig. 2. (a-d) Kaplan-Meier curves for time to (a) Death, (b) ESKD, (c) CVE and (d) any event for each group (adjusted for age, gender, macrovascular disease, flash pulmonary oedema, diabetes and baseline eGFR and proteinuria).
© 2016 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4.0

3. Three Decades of Atherosclerotic Reno-vascular Disease Management - Changing Outcomes in an Observational Study
Kidney Blood Press Res 2016;41: DOI: /
Fig. 3. Number of patients diagnosed with ARVD and number of revascularization procedures performed each year in relation to important events and turning points in the history of management of ARVD.
© 2016 The Author(s) Published by S. Karger AG, Basel - CC BY-NC-ND 4.0